HomeCompareJTAIZ vs MRK

JTAIZ vs MRK: Dividend Comparison 2026

JTAIZ yields 1953.13% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JTAIZ wins by $7970909019.22M in total portfolio value
10 years
JTAIZ
JTAIZ
● Live price
1953.13%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7970909019.28M
Annual income
$7,241,553,183,211,343.00
Full JTAIZ calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — JTAIZ vs MRK

📍 JTAIZ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJTAIZMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JTAIZ + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JTAIZ pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JTAIZ
Annual income on $10K today (after 15% tax)
$166,015.63/yr
After 10yr DRIP, annual income (after tax)
$6,155,320,205,729,641.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, JTAIZ beats the other by $6,155,320,205,721,313.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JTAIZ + MRK for your $10,000?

JTAIZ: 50%MRK: 50%
100% MRK50/50100% JTAIZ
Portfolio after 10yr
$3985454509.67M
Annual income
$3,620,776,591,610,570.50/yr
Blended yield
90.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

JTAIZ
No analyst data
Altman Z
-3.3
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JTAIZ buys
0
MRK buys
0
No recent congressional trades found for JTAIZ or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJTAIZMRK
Forward yield1953.13%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$7970909019.28M$56.8K
Annual income after 10y$7,241,553,183,211,343.00$9,798.13
Total dividends collected$7919045780.26M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: JTAIZ vs MRK ($10,000, DRIP)

YearJTAIZ PortfolioJTAIZ Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$206,013$195,312.50$11,206$366.19+$194.8KJTAIZ
2$3,980,884$3,760,450.13$12,650$502.35+$3.97MJTAIZ
3$72,170,831$67,911,285.69$14,407$694.19+$72.16MJTAIZ
4$1,227,865,292$1,150,642,502.96$16,585$967.82+$1227.85MJTAIZ
5$19,609,373,528$18,295,557,664.88$19,342$1,363.89+$19609.35MJTAIZ
6$294,052,582,671$273,070,552,997.00$22,913$1,947.19+$294052.56MJTAIZ
7$4,141,582,588,776$3,826,946,325,317.78$27,662$2,823.89+$4141582.56MJTAIZ
8$54,805,897,435,500$50,374,404,065,509.74$34,159$4,173.35+$54805897.40MJTAIZ
9$681,640,968,289,556$622,998,658,033,571.10$43,337$6,308.80+$681640968.25MJTAIZ
10$7,970,909,019,281,168$7,241,553,183,211,343.00$56,776$9,798.13+$7970909019.22MJTAIZ

JTAIZ vs MRK: Complete Analysis 2026

JTAIZStock

Jet.AI Inc. develops private aviation platform. It operates in two segments, Software and Aviation. The Software segment develops a B2C CharterGPT application that uses natural language processing and machine learning to improve the private booking experience; a B2B Jet; and AI Operator Platform that offers a suite of stand-alone software products to enable charter providers to add revenue, maximize efficiency, and reduce environmental impact. The Aviation segment is involved in jet aircraft fraction sales, jet card sales, on-fleet charter, management, and buyer's brokerage. The company was founded in 2018 and is based in Las Vegas, Nevada.

Full JTAIZ Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this JTAIZ vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JTAIZ vs SCHDJTAIZ vs JEPIJTAIZ vs OJTAIZ vs KOJTAIZ vs MAINJTAIZ vs JNJJTAIZ vs ABBVJTAIZ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.